Cover Image
市場調查報告書

睪丸癌:全球臨床實驗檢討

Testicular Cancer Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 227699
出版日期 內容資訊 英文 147 Pages
訂單完成後即時交付
價格
Back to Top
睪丸癌:全球臨床實驗檢討 Testicular Cancer Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月19日 內容資訊: 英文 147 Pages
簡介

本報告提供全球睪丸癌治療藥物的臨床實驗的相關調查,各地區臨床實驗數資料,實驗階段,實驗情形,採用題目及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 睪丸癌
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗, 各國
  • 對臨床實驗有所貢獻的前五國 - 歐洲
  • 對臨床實驗有所貢獻的前幾名國家 - 北美
  • 對臨床實驗有所貢獻的前幾名國家 - 中東及非洲
  • 對臨床實驗有所貢獻的前幾名國家 - 中南美
  • 臨床實驗 - 金磚四國 各國
  • 臨床實驗 - G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 - E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 臨床實驗 各階段
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 睪丸癌
  • 每段時期的實驗人數
  • 有力的贊助商
  • 前幾名參與企業 - 睪丸癌 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 前幾名企業
  • The EMMES Corporation
  • 臨床實驗概要; The EMMES Corporation
  • Cell Medica Limited
  • 臨床實驗概要; Cell Medica Limited
  • MannKind Corporation
  • 臨床實驗概要; MannKind Corporation
  • Oncology, Inc.
  • 臨床實驗概要; Oncology, Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Memorial Sloan Kettering Cancer Center
  • 臨床實驗概要; Memorial Sloan Kettering Cancer Center
  • European Organization for Research and Treatment of Cancer
  • 臨床實驗概要; European Organization for Research and Treatment of Cancer
  • The University of Texas M. D. Anderson Cancer Center
  • 臨床實驗概要; The University of Texas M. D. Anderson Cancer Center
  • Fred Hutchinson Cancer Research Center
  • 臨床實驗概要; Fred Hutchinson Cancer Research Center
  • Stanford University
  • 臨床實驗概要; Stanford University
  • Dana-Farber Cancer Institute
  • 臨床實驗概要; Dana-Farber Cancer Institute
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • 臨床實驗概要; Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Vanderbilt-Ingram Cancer Center
  • 臨床實驗概要; Vanderbilt-Ingram Cancer Center
  • Federation Nationale des Centres de Lutte Contre le Cancer
  • 臨床實驗概要; Federation Nationale des Centres de Lutte Contre le Cancer
  • Wake Forest University
  • 臨床實驗概要; Wake Forest University
  • Indiana University
  • 臨床實驗概要; Indiana University
  • Alberta Health Services
  • 臨床實驗概要; Alberta Health Services
  • University Medical Center Groningen
  • 臨床實驗概要; University Medical Center Groningen
  • IU Simon Cancer Center
  • 臨床實驗概要; IU Simon Cancer Center
  • Dartmouth-Hitchcock Medical Center
  • 臨床實驗概要; Dartmouth-Hitchcock Medical Center
  • Hannover Medical School
  • 臨床實驗概要; Hannover Medical School
  • St George's University of London
  • 臨床實驗概要; St George's University of 倫敦
  • University of Copenhagen
  • 臨床實驗概要; University of Copenhagen
  • Rigshospitalet
  • 臨床實驗概要; Rigshospitalet
  • Centre Hospitalier Universitaire de Nice
  • 臨床實驗概要; Centre Hospitalier Universitaire de Nice
  • 5大主要臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 睪丸癌 全球治療藥物市場, 臨床實驗 各地區
  • 睪丸癌 全球治療藥物市場, 臨床實驗 , 各國排名
  • 睪丸癌 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 睪丸癌 治療藥物的臨床實驗, 歐洲, 前五國
  • 睪丸癌 治療藥物的臨床實驗, 北美, 前幾名國家
  • 睪丸癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家
  • 睪丸癌 治療藥物的臨床實驗, 中南美, 前幾名國家
  • 睪丸癌 治療藥物的臨床實驗, 金磚四國 各國
  • 睪丸癌 治療藥物的臨床實驗, G7 各國
  • 睪丸癌 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 睪丸癌 治療藥物的臨床實驗, E7 各國
  • 睪丸癌 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 睪丸癌 全球治療藥物市場, 臨床實驗 各階段
  • 睪丸癌 全球治療藥物市場, 進行中的臨床實驗 各階段 2011*
  • 睪丸癌 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 睪丸癌 全球治療藥物市場, 暫時停止的臨床實驗
  • 睪丸癌 全球治療藥物市場, 中止的臨床實驗
  • 睪丸癌 全球治療藥物市場, 終止的臨床實驗
  • 睪丸癌 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
  • 睪丸癌 全球治療藥物臨床實驗, 主要的贊助商
  • 睪丸癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 睪丸癌 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- The EMMES Corporation
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Cell Medica Limited
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- MannKind Corporation
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Oncology, Inc.
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Memorial Sloan Kettering Cancer Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- European Organization for Research and Treatment of Cancer
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- The University of Texas M. D. Anderson Cancer Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Fred Hutchinson Cancer Research Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Stanford University
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Dana-Farber Cancer Institute
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Vanderbilt-Ingram Cancer Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Federation Nationale des Centres de Lutte Contre le Cancer
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Wake Forest University
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Indiana University
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Alberta Health Services
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- University Medical Center Groningen
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- IU Simon Cancer Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Dartmouth-Hitchcock Medical Center
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Hannover Medical School
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- St George's University of 倫敦
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- University of Copenhagen
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Rigshospitalet
  • 睪丸癌 全球治療藥物臨床實驗市場, 臨床實驗- Centre Hospitalier Universitaire de Nice

圖表一覽

圖表一覽

  • 睪丸癌 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 睪丸癌 全球治療藥物市場, 臨床實驗 , 各國排名
  • 睪丸癌 全球治療藥物市場, 進行中的臨床實驗 , 各國排名
  • 睪丸癌 治療藥物的臨床實驗, 歐洲, 前五國 (%)
  • 睪丸癌 治療藥物的臨床實驗, 北美, 前幾名國家 (%)
  • 睪丸癌 治療藥物的臨床實驗, 中東及非洲, 前幾名國家 (%)
  • 睪丸癌 治療藥物的臨床實驗, 中南美, 前幾名國家 (%)
  • 睪丸癌 治療藥物的臨床實驗, G7 各國 (%)
  • 睪丸癌 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 睪丸癌 全球治療藥物市場, 臨床實驗 各階段 (%)
  • 睪丸癌 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 睪丸癌 全球治療藥物市場, 臨床實驗 , 各臨床實驗狀態
  • 睪丸癌 全球治療藥物臨床實驗, 平均登錄對像人數趨勢
  • 睪丸癌 全球治療藥物臨床實驗, 主要的贊助商
  • 睪丸癌 全球治療藥物臨床實驗, 前幾名企業 各階段
  • 睪丸癌 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3408CTIDB

GlobalData's clinical trial report, "Testicular Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Testicular Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Testicular Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Testicular Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Testicular Cancer Therapeutics, Global, Clinical Trials by Region, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Testicular Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Testicular Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Testicular Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Testicular Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Testicular Cancer to Oncology Clinical Trials, G7 Countries (%), 2016*
  • Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Testicular Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Testicular Cancer to Oncology Clinical Trials, E7 Countries (%), 2016*
  • Testicular Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Testicular Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Testicular Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Testicular Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Testicular Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top